Y. Aizawa et al., PROCAINAMIDE INDUCED CHANGE OF THE WIDTH OF THE ZONE OF ENTRAINMENT AND ITS RELATION TO THE INDUCIBILITY OF REENTRANT VENTRICULAR-TACHYCARDIA, PACE, 20(11), 1997, pp. 2789-2798
AIZAWA, Y., ET AL.: Procainamide Induced Change of the Width of the Zo
ne of Entrainment and its Relation to the Inducibility of Reentrant Ve
ntricular Tachycardia. Procainamide depresses conduction velocity and
prolongs refractoriness in myocardium responsible for reentrant VT, bu
t the mechanism by which the induction of VT is suppressed after proca
inamide administration remains to be determined. In the present study,
the relationship between electrophysiological parameters and the noni
nducibility of VT was assessed during procainamide therapy with a spec
ial reference to the change of an excitable gap. Clinically documented
monomorphic sustained VT was induced in 30 patients and, utilizing th
e phenomenon of transient entrainment, the zone of entrainment was mea
sured as the difference between the cycle length of VT and the longest
paced cycle length interrupting VT (block cycle length) which was det
ermined as the paced cycle length decreased in steps of 10 ms, and use
d as an index of the excitable gap. The effective refractory period wa
s measured at the pacing site and the paced QRS duration was used as a
n index of the global conduction time in the ventricle. The cycle leng
th of VT, the block cycle length, and the width of the zone of entrain
ment were determined and compared between the responders and nonrespon
ders. In 15 patients, these parameters were determined at the intermed
iate dose and related to subsequent noninducibility at the final dose.
At the final doses of procainamide, VT was suppressed in 8 (26.7%) of
30 patients. However the cycle length of VT, the block cycle length,
and the width of the zone of entrainment were unable to predict the dr
ug efficacy i.e., noninducibility. The change in the effective refract
ory period at the pacing site or the width of the paced QRS duration w
as not different between the responders and nonresponders. Among the v
ariables, only the width of the zone of entrainment showed a significa
nt narrowing in the responders at the intermediate dose of procainamid
e, and it was smaller than that of the nonresponders. The significant
narrowing of the width of the zone of entrainment was associated with
the subsequent noninducibility of TIT at the final dose. The present s
tudy showed that the baseline cycle length of VT, the block cycle leng
th, the drug induced change of the effective refractory period, or the
paced QRS duration was not a predictor of the noninducibility after p
rocainamide administration. However, a significant narrowing of the wi
dth of the zone of entrainment at the intermediate dose was associated
with the noninducibility of VT at the final dose.